31.68 USD
↘ 0.13 (0.41%)AT CLOSE (03:59 PM EDT)
Arcutis Biotherapeutics, Inc. Common Stock
ARQTNASDAQ • USD
32.01
↗ 0.33 (1.04%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
32.01
↗ 0.33 (1.04%)
Market: CLOSED
Arcutis Biotherapeutics, Inc. Common Stock (ARQT) is currently trading at $31.67. Both sides of the analysis agree: technicals flash "Strong Buy" and fundamentals confirm with a "Buy" reading. Key drivers include a robust Altman Z-Score, a bullish Golden Cross on the moving averages and bullish moving average alignment. Furthermore, ARQT is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Oct 27, 2026.
Open?$31.40
High?$32.11
Low?$31.18
Prev. Close?$31.81
Volume?2.2M
Avg. Volume?3.2M
VWAP?$31.76
Rel. Volume?0.70x
Bid / Ask
Bid?$31.65 × 100
Ask?$32.74 × 200
Spread?$1.09
Midpoint?$32.20
Valuation & Ratios
Market Cap?4.0B
Shares Out?125.7M
Float?113.5M
Float %?90.3%
P/E Ratio?139.62
P/B Ratio?18.05
EPS?$0.23
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.
Address
3027 TOWNSGATE ROAD
WESTLAKE VILLAGE, CA 91361
Phone: 805-418-5006
WESTLAKE VILLAGE, CA 91361
Phone: 805-418-5006
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?60
Z-Score?100
Momentum?85
Short Sent.?50
Piotroski F-Score?5/9Mixed
Altman Z-Score?7.64Safe
Confidence?67%Moderate
Short InterestHigh
Short % of Float?18.04%High
Short Interest?20.5M
Days to Cover?9.8
Free Float113.5M
Avg Daily Volume2.1M
Settlement Date2026-10-15
Financial Health
Current Ratio?2.92Strong
Quick Ratio?2.67Strong
Cash Ratio?0.21Low
Debt/Equity?0.49Low
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score33/100
P/E?139.6PRICEY▾
Peers100
S&P3
P/B?18.05HIGH▾
Peers100
S&P9
P/S?8.58HIGH▾
Peers100
S&P11
P/FCF?101.7PRICEY▾
Peers100
S&P3
EV/EBITDA?132.1HIGH▾
Peers100
S&P3
EV/Sales?8.74HIGH▾
Peers100
S&P14
Returns & Efficiency
ROE?12.9%STRONG▾
Peers50
S&P47
ROA?5.8%FAIR▾
Peers50
S&P52
Cash Flow & Enterprise
FCF?$39.2M
Enterprise Value?$4.1B
Fundamentals ratios updated end of day